ABSTRACT
The low prevalence of European paediatric transplanted patients and scarcity of resources and expertise led to the need for a multidisciplinary network able to improve the quality of life of paediatric patients and families requiring a solid organ or haematopoietic stem cell transplantation. The European Reference Network (ERN) TransplantChild is one of the 24 ERNs established in a European legal framework to improve the care of patients with rare diseases. ERN TransplantChild is the only ERN focused on both solid organ and haematopoietic stem cell paediatric transplantation, based on the understanding of paediatric transplantation as a complex and highly specialised process where specific complications appear regardless the organ involved, thus linking the skills and knowledge of different organ disciplines. Gathering European centres of expertise in paediatric transplantation will give access to a correct and timely diagnosis, share expertise and knowledge and collect a critical mass of patients and data that increases the speed and value of clinical research outcomes. Therefore, the ERN TransplantChild aims for a paediatric Pan-European, Pan-transplant approach.
Subject(s)
Hematopoietic Stem Cell Transplantation/methods , Organ Transplantation/methods , Europe , Geography , Humans , Models, Theoretical , Quality of Life , Surgical Procedures, OperativeABSTRACT
Fenton's reagent was used to isolate microplastics from organic-rich wastewater. The catalytic reaction did not affect microplastic chemistry or size, enabling its use as a pre-treatment method for focal plane array-based micro-FT-IR imaging. Compared with previously described microplastic treatment methods, Fenton's reagent offers a considerable reduction in sample preparation times.
Subject(s)
Chemical Fractionation/methods , Hydrogen Peroxide/chemistry , Iron/chemistry , Plastics/isolation & purification , Wastewater/chemistry , Water Pollutants, Chemical/isolation & purification , Plastics/chemistry , Time Factors , Water Pollutants, Chemical/chemistryABSTRACT
The objective of this study was to evaluate in native cattle the use of an in vitro derived attenuated live vaccine (Babesia bovis-Babesia bigemina). Three commercial farms located in a tropical region in Chiapas State, Mexico were included. For each ranch, 40 animals were selected as negative to Babesia spp. by using an immunofluorescent antibody test (IFAT) and PCR. Animals were distributed in four groups with 10 animals each: (i) <9 months, (ii) 9-18, (iii) 18-36 and (iv) >36 months old. From each group, two subgroups were formed with five animals each; one subgroup was vaccinated and the other served as control without vaccination. Monitoring and sampling were carried out initially at vaccination (day 0), at day 7 and then every 4 weeks for 12 months. During the study rectal temperature ( degrees C), packed cell volume (Ht %) and percentage of erythrocytes parasitized were registered, furthermore IFAT and PCR were performed. Prevalence rate at the beginning of the study was 83% by IFAT. During the survey, 26 non-vaccinated of the 120 selected animals (43%) showed clinical symptoms of babesiosis, confirmed by stained smears versus only four (6.6%) of the vaccinated ones. All Babesia-affected animals required specific treatment. Vaccinated cattle showed titres of up to 1 : 1840 and 1 : 1027 for B. bovis and B. bigemina, respectively by IFAT. Protection conferred by vaccination was about 93%. We propose that this vaccine should not only be used in cattle coming from babesiosis free zones, but also in native cattle kept in hyperendemic areas.
